Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAZ320 in Type 2 Diabetes Patients Treated with Metformin
NCT04569214Phase 2Withdrawn
- Sponsor
- Boston Therapeutics, Inc.
- Start
- Sep 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BTI320 in type 2 diabetes mellitus (T2DM), sponsored by Boston Therapeutics, Inc.. Planned start Sep 2012; status: withdrawn.
02
Drugs
BTI320
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04569214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04569214.